Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.3795
-0.0107 (-2.74%)
At close: Oct 14, 2026, 4:00 PM EDT
0.3771
-0.0024 (-0.63%)
After-hours: Oct 14, 2026, 7:41 PM EDT
Evogene Employees
Evogene had 52 employees as of December 31, 2025. The number of employees decreased by 65 or -55.56% compared to the previous year.
Employees
52
Change (1Y)
-65
Growth (1Y)
-55.56%
Revenue / Employee
$31,865
Profits / Employee
-$174,481
Market Cap
6.03M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 52 | -65 | -55.56% | 52 | 0 |
| Dec 31, 2024 | 117 | -25 | -17.61% | 117 | 0 |
| Dec 31, 2023 | 142 | 5 | 3.65% | 142 | 0 |
| Dec 31, 2022 | 137 | -4 | -2.84% | 137 | 0 |
| Dec 31, 2021 | 141 | 10 | 7.63% | 141 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Imunon | 20 |
| NeuroSense Therapeutics | 17 |
| FibroBiologics | 15 |
| Traws Pharma | 7 |
| Enveric Biosciences | 6 |
| Alzamend Neuro | 6 |
| Can-Fite BioPharma | 5 |
| XTL Biopharmaceuticals | 5 |
EVGN News
- 8 days ago - Evogene (EVGN) Forms Strategic Partnership to Resolve Disputes and Stabilize Operations - GuruFocus
- 8 days ago - Evogene announces cooperation agreement with Pure Capital Group - TheFly
- 8 days ago - Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors - PRNewsWire
- 14 days ago - Evogene Gets 180-day Nasdaq Extension To Regain Compliance - Nasdaq
- 14 days ago - Evogene receives non-compliance letter from Nasdaq - TheFly
- 14 days ago - Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance - PRNewsWire
- 6 weeks ago - Evogene responds to latest communication from L.I.A. Pure Capital, Invest-Pro - TheFly
- 6 weeks ago - Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward - PRNewsWire